DanCann Pharma AS
DAN0
Company Profile
Business description
DanCann Pharma AS is a Danish biopharmaceutical Company powered by cannabinoids. DanCann Pharma is a licensed production and distribution Company. The company is focused on discovering, developing, manufacturing, and commercializing novel cannabinoid therapeutics for a broad range of diseases.
Contact
Rugvaenget 5
AnsagerDK-6823
DNKT: +45 6916393
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
5
Stocks News & Analysis
stocks
After slump this ASX share may be an opportunity
Lower than expected guidance led to a sell-off.
stocks
Investment decisions in overvalued bank drive strong results
Shares fall despite a broadly unchanged outlook.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,104.20 | 48.00 | -0.52% |
| CAC 40 | 8,055.51 | 105.33 | 1.32% |
| DAX 40 | 23,959.99 | 390.03 | 1.65% |
| Dow JONES (US) | 47,368.63 | 381.53 | 0.81% |
| FTSE 100 | 9,787.15 | 104.58 | 1.08% |
| HKSE | 26,603.20 | 45.86 | -0.17% |
| NASDAQ | 23,527.17 | 522.64 | 2.27% |
| Nikkei 225 | 51,131.28 | 219.52 | 0.43% |
| NZX 50 Index | 13,586.63 | 30.85 | -0.23% |
| S&P 500 | 6,832.43 | 103.63 | 1.54% |
| S&P/ASX 200 | 8,825.50 | 50.10 | -0.56% |
| SSE Composite Index | 4,004.89 | 13.70 | -0.34% |